Research Projects

LAZARO. Development of caspase-2 inhibitors as a first-in-class therapy for treating non-alcoholic steatohepatitis.


Project information

LÁZARO is a collaborative R&D project with companies created to develop caspase-2 inhibitors as a first-in-class therapy for the treatment of non-alcoholic steatohepatitis.

It is led by Dr. Matías Ávila and is funded by CPP2021-008411 MCIN/AEI/10.13039/ 501100011033 and by the European Union-NextGenerationEU/PRTR. The Spanish Ministry of Science and Innovation funds it.

  • Convocation: FIMA 2021 MCI - AEI PUBLIC-PRIVATE PARTNERSHIPS PROJECTS
  • Reference: CPP2021-008411
  • Start date: February 21, 2022
  • End date: February 20, 2025
  • Funder: Ministerio de Ciencia e Innovación
  • Nature of project: National
  • Award year 2022

Need more information?

If you are interested in learning more about our research, please contact us